Joseph W Rossano
Joseph W Rossano is an expert in Cardiology at Children's Hospital of Philadelphia (United States). As of October 2026, ScienceLeadR ranks Joseph W Rossano in the top 1% of experts worldwide for Heart Transplantation, Cardiomyopathies and Cardiovascular Abnormalities. Joseph W Rossano has authored 583 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 4 of them ongoing. SLR score: 2,197 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Transplantation - Pediatrics - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 583
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The Compassionate Pediatric Cardiology Program. PMID 42955293 — heart diseases, communication, workload, cardiology, work | Pediatr Cardiol | 2026 | 0 |
| Genotype, Phenotypic Severity, and Survival in Pediatric Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry. PMID 42935448 — registries, cardiomyopathy, dilated, genes, heart failure, heart, echocardiography, genotype, diagnosis, transplants, cardiomyopathies, child | Circ Heart Fail | 2026 | 0 |
| Greater Neighborhood Resources Predict Reduced In-Hospital Death for Children With Heart Failure and Cardiomyopathy. PMID 42924833 — heart diseases, heart failure, heart, cardiomyopathies, child | J Am Heart Assoc | 2026 | 0 |
| Body Mass Index, Valsartan, and Myocardial Remodeling in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the Randomized VANISH Trial. PMID 42858009 — valsartan, heart diseases, body mass index, cardiomyopathy, hypertrophic, angiotensin receptor antagonists, obesity, cardiomyopathies | J Am Heart Assoc | 2026 | 0 |
| Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry. PMID 42417692 — registries, natural history, heart failure, atrial fibrillation, cardiology, signs and symptoms, therapeutics, history | J Am Coll Cardiol | 2026 | 5 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy NCT06253221 — cardiomyopathy, hypertrophic, adolescent, cardiomyopathies | Phase 3 | Active not recruiting | 2024 |
| A Gene Therapy Study of RP A501 in Male Patients With Danon Disease NCT06092034 — muscular diseases, genes, glycogen, hypertrophy, left ventricular, immunomodulation, glycogen storage disease, safety, protein isoforms, adrenal cortex hormones, sirolimus, genome, glycogen storage disease type iib, hypertrophy, lysosomal storage diseases, transgenes, cardiomyopathy, hypertrophic, capsid, rituximab, viruses, genes, vif, satellite viruses, therapeutics, cardiomyopathies, genes, x-linked, biosimilar pharmaceuticals, male | Phase 2 | Recruiting | 2023 |
| A Phase 1 Dose Escalation Trial of RP A601 in Subjects With PKP2 Variant Mediated Arrhythmogenic Cardiomyopathy (PKP2 ACM) NCT05885412 — genes, death, sudden, heart, arrhythmias, cardiac, transgenes, capsid, heart arrest, arrhythmogenic right ventricular dysplasia, viruses, satellite viruses, death, sudden, cardiac, therapeutics, plakophilins, cardiomyopathies | Phase 1 | Recruiting | 2023 |
| Intramyocardial Injection of Autologous UCB MNC During Fontan Surgery for SRV Dependent CHD NCT04907526 — heart defects, congenital, injections, cells, congenital abnormalities, heart diseases, blood, microscopy, electron, scanning transmission, heart, stem cells, hypoplastic left heart syndrome, therapeutics, umbilical cord | Phase 1 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map